EPISODE · Jan 10, 2022 · 9 MIN
Innodem and Novartis to Test Eye-tracking Technology & Managing Certain MS Accidents
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Innodem and Novartis Canada are launching a clinical trial to evaluate biomarker eye-tracking technology for monitoring MS progression.Plus, Price reads “My Coffee Cup Runneth Over, Plus a Darned Interruption”, a column by John Connor.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
NOW PLAYING
Innodem and Novartis to Test Eye-tracking Technology & Managing Certain MS Accidents
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m